AGMB
AgomAb Therapeutics NV American Depositary Shares
NASDAQ: AGMB · HEALTHCARE · BIOTECHNOLOGY
$10.74
+0.94% today
Updated 2026-04-29
Market cap
$528.92M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.50
Dividend yield
—
52W range
$9 – $17
Volume
0.2M
AgomAb Therapeutics NV American Depositary Shares (AGMB) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-39.20%
ROA
-20.60%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2022 | $0.00 | $-8.14M | — | — | — |
| 2023 | $0.00 | $-11.39M | — | — | — |
| 2024 | $0.00 | $-46.27M | — | — | — |
| 2025 | $0.00 | $-46.27M | — | — | — |